1. Introduction {#sec0005}
===============

Rotavirus A (Group A rotavirus, RVA) is the leading etiological agent of severe gastroenteritis in infants and young children worldwide, and is estimated to cause 197,000 deaths in children \<5 years of age ([@bib0130]). As enteric pathogens, RVAs circulate in mammals and birds. Rotavirus is a genus of the family *Reoviridae*, and its genome is composed of 11 segments of double-stranded RNA enclosed in a triple-layered capsid. RNA segments of RVA encode six structural proteins (VP1-VP4, VP6 and VP7) and six nonstructural proteins (NSP1-NSP6) ([@bib0060]). Due to the segmented nature of the rotavirus genome, reassortment is considered to occur occasionally when co-infection with more than one rotavirus genotype occurs in hosts ([@bib0095]; [@bib0170]; [@bib0225]). This reassortment has been revealed by whole genomic analysis ([@bib0075]).

The outermost layer of the rotavirus particle consists of two structural proteins VP7 and VP4, on which neutralization antigens are present and define independent serotypes (G and P serotypes, respectively). Based on the VP7 and VP4 genes, RVA has been genetically classified into G type and P type, respectively ([@bib0060]). A total of 27 G types and 37 P types have been described to date for human and animal rotaviruses ([@bib0145]; [@bib0220]). Genotypes G1P\[8\], G2P\[4\], G3P\[8\], G4P\[8\], G9P\[8\], G12P\[8\] and combinations thereof, are frequently detected in human RVAs throughout the world ([@bib0210]; [@bib0055]). A comprehensive genetic analysis of all 11 segments revealed that there are two major genotype constellations in human rotaviruses (HRVs). The Wa genogroup (Wa-like genotype constellation) includes strains with G1P\[8\], G3P\[8\], or G4P\[8\] genotypes, and the DS-1 genogroup (DS-1-like genotype constellation) is usually associated with G2P\[4\] HRV strains ([@bib0140]).

G2P\[4\], one of the most common HRV genotypes worldwide, has been showing relatively high detection rates (16--36%) in South Asia recently ([@bib0055]; [@bib0175]; [@bib0180]). In Bangladesh, G2 has occasionally been the most common genotype among circulating HRVs for the past 20 years, while G9 and G12 emerged as predominant strains in the last decade ([@bib0005]; [@bib0010]; [@bib0015]; [@bib0035]; [@bib0175]; [@bib0195]). The reason for the occasional dominance of G2P\[4\] HRV in Bangladesh has not yet been fully understood, although the occurrence of multiple lineages of VP7 gene is suggested to be one of the possible reasons ([@bib0010]).

G2P\[4\] genotype has been known to increase or persist in dominance after introduction of monovalent rotavirus vaccine in Brazil, Argentina, Australia, Belgium, and Korea ([@bib0100]; [@bib0110]; [@bib0120]; [@bib0125]; [@bib0135]; [@bib0150]). Therefore, it is important to understand diversity and genetic evolution of G2P\[4\] HRVs in nature and their association with efficacy of vaccines. Whole genomic analysis of HRVs revealed presence of three distinct clades among G2P\[4\] in 2010--2011 winter season in the USA ([@bib0030]). Furthermore, long-term investigations of whole genome of G2P\[4\] HRVs in Italy ([@bib0085]) and Japan ([@bib0045]) indicated occurrence of major genomic change in the global G2P\[4\] RVAs in the early 2000s.

In Bangladesh, genetic diversity and evolution of G2P\[4\] RVAs was analyzed in terms of VP7 gene from a large number of G2P\[4\] strains ([@bib0010]). In this study, Afrad and coworkers revealed that multiple lineages of G1 and G2 HRVs had been co-circulating over the years. Whole genomes of HRV G1, G2 and G12 strains in Bangladesh were previously analyzed ([@bib0080]; [@bib0200]; [@bib0205]), with only two G2P\[4\] HRV strains available for study ([@bib0080]). Thus, the genomic diversity of G2P\[4\] HRVs in Bangladesh have not yet been well characterized using whole genome sequencing. The purpose of the present study was to elucidate evolutionary state of all the gene segments of G2P\[4\] HRVs, i.e., to understand genetic diversity of individual genome segments and correlation of evolution among gene segments. In the present study, we analyzed whole genome of 16 G2P\[4\] HRV strains in 2010 and 2013 to obtain clues to understand their persistence in Bangladesh.

2. Material and methods {#sec0010}
=======================

2.1. Virus strains {#sec0015}
------------------

A total of 17 G2P\[4\] HRV strains isolated from diarrheal stool samples collected from patients aged 3 months to 24 years in Mymensingh, Bangladesh were studied. Nine and eight HRV strains were obtained in Jan.--Feb. 2010 and Aug.--Dec. 2013, respectively ([Table 1](#tbl0005){ref-type="table"}). In 2010, G2 was the most prevalent (41%), followed by G1 (25%), and G9 (8%), in Mymensingh (unpublished data). Genotyping results of HRV in 2013 have not yet been available. All the strains were confirmed to have G2P\[4\] genotypes by semi-nested RT-PCR as described previously ([@bib0105]; [@bib0185]). For the experiments, utmost attention was paid to avoid contamination especially in handling stool specimens, for example, using only one sample per day for RNA extraction and RT-PCR.

2.2. Nucleotide sequencing, genotyping and sequence analyses {#sec0020}
------------------------------------------------------------

Viral RNA was extracted from stool samples using the QIAamp Viral RNA Mini Kit (Qiagen Science, MD, USA). RT-PCRs were performed using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) and Prime Star GXL DNA polymerase (TaKaRa, Japan). Primers used for amplification of viral genome segments have been described previously ([@bib0065]; [@bib0070]; [@bib0080]). For the RT-PCR of VP1-4, NSP1, and NSP4 genes, additional primers were designed in the present study as shown in [Table 2](#tbl0010){ref-type="table"}. Nucleotide sequences were determined by the Sanger method using the BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA) on an automated DNA sequencer (ABI PRISM 3100). The Basic Local Alignment Search Tool (BLAST) (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) was used to search for the most similar rotavirus gene sequence and assign its genotype based on cut-off values indicated by Rotavirus Classification Working Group ([@bib0145]). Phylogenetic trees of individual gene segments were constructed by Maximum Likelihood method using MEGA6 software ([@bib0215]), with sequences selected from GenBank database. Phylogenetic trees were statistically supported by bootstrapping with 1000 replicates, and phylogenetic distances were measured by the Kimura two-parameter model ([@bib0115]). Multiple alignments of sequences were performed using CLUSTAL W ver. 2.1 program available on website of DDBJ (<http://clustalw.ddbj.nig.ac.jp/>). Sequence identity of a pair of gene sequences was determined by using LALIGN program on web server (<http://www.ch.embnet.org/software/LALIGN_form.html>).

2.3. Nucleotide sequence accession numbers {#sec0025}
------------------------------------------

The GenBank accession numbers for the nucleotide sequences determined in the present study were listed in [Table 3](#tbl0015){ref-type="table"}.

3. Results {#sec0030}
==========

The genotype constellation of 16 strains in this study was G2-P\[4\]-I2-R2-C2-M2-A2-N2-T2-E2-H2, showing typical DS-1-like genotype constellation. One strain J331 detected in 2010 had the genotype constellation G2-P\[4\]-I2-R2-C2-M1-A2-N2-T2-E2-H1, which contained genotypes of Wa genogroup (M1 and H1). Because the possibility of mixed infection with Wa genogroup HRV could not be excluded, strain J331 was not included in the phylogenetic analysis with other G2P\[4\] strains.

VP2, VP4, VP6, VP7, NSP1-3 and NSP5 genes from the 16 G2P\[4\] strains exhibited high level sequence conservation with \>98% sequence identity to each other. In contrast, slight sequence diversity was observed for VP1, VP3, and NSP4 genes among the 16 strains (94.4%, 90.6%, and 94.3% sequence identity, respectively). Phylogenetic analysis together with representative G2P\[4\] RVAs from the world ([@bib0020]; [@bib0025]; [@bib0045]; [@bib0080]; [@bib0085]; [@bib0190]) indicated that most of the Bangladeshi G2 HRV genome segments were classified into a single lineage (lineage V), while VP3 and NSP4 genes were assigned to two (V, VI) and three lineages (V--VII), respectively ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}, [Fig. 5](#fig0025){ref-type="fig"}, [Fig. 6](#fig0030){ref-type="fig"}, [Fig. 7](#fig0035){ref-type="fig"}, [Fig. 8](#fig0040){ref-type="fig"}, [Fig. 9](#fig0045){ref-type="fig"}, [Fig. 10](#fig0050){ref-type="fig"}, [Fig. 11](#fig0055){ref-type="fig"}). We followed designation of lineages in each RNA segment as described by [@bib0045].

Within the lineage V, if the sequences of present Bangladeshi HRVs clustered in a branch supported with high bootstrap value, sublineage was designated with a subscript attached with lineage V ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}, [Fig. 5](#fig0025){ref-type="fig"}, [Fig. 6](#fig0030){ref-type="fig"}, [Fig. 7](#fig0035){ref-type="fig"}, [Fig. 8](#fig0040){ref-type="fig"}, [Fig. 9](#fig0045){ref-type="fig"}, [Fig. 10](#fig0050){ref-type="fig"}, [Fig. 11](#fig0055){ref-type="fig"}). A subscript "a" was assigned to five strains in 2013 because they clustered together in all the gene segments, and subscript b and c were assigned arbitrarily. G2P\[4\] strains in 2013 had mostly gene segments belonging to sublineage Va, while several genes of three strains were not assigned to lineage Va. In contrast, G2P\[4\] strains in 2010 were more divergent than 2013 strains, because individual gene segments belonged to various sublineages or were not assigned to the sublineages. Based on combination of sublineages (lineages) in 11 gene segments, G2P\[4\] HRVs in 2010 and 2013 were classified into four lineage constellations each ([Table 4](#tbl0020){ref-type="table"}). In terms of the similarity of lineage constellations (five or more identical sublineages of lineage V, and lineages VI and VII), the eight strains each in 2010 and 2013 were classified into three clades (A-C) and one clade (D), respectively.

All the genome segments of HRV strains analyzed in the present study clustered with those of G2P\[4\] HRV strains MMC6 and/or MMC88 detected in Bangladesh in 2005 ([@bib0080]) and other contemporary G2P\[4\] strains from Americas, Asia, etc., within the lineage V, in the phylogenetic trees. However, clustering patterns with strains MMC6 and/or MMC88 were different depending on gene segments. Strains MMC6 and MMC88 had VP1, VP2, VP4, VP6, NSP1, NSP2, NSP5/6 genes classified into sublineages Vb or Vc. However, only VP3 gene of MMC88 was assigned to sublineage Va. VP7 gene of MMC6 and MMC88 did not cluster with the lineage Va. NSP4 genes of lineage VI (MMC6) and VII (MMC88) clustered with clade C and B strains, respectively.

Between sublineages Va and Vb, sequence identity of VP1 genes was approximately 94%, while \>97.9 identity was found within the same sublineages. Lineage VI and VII NSP4 genes exhibited 94% identity to sublineage Va NSP4 genes. VP3 genes of sublineage Va showed 90.6% identity to those of lineage VI strains, in contrast to \>99% identity among Va lineage.

Amino acid residues in VP7 defining neutralization domain of the G2P\[4\] strains in 2010 and 2013 were mostly identical to those of MMC88 strain in 2005, although one or two amino acid difference was found with strains J251 and J253 in 2010, and M313 and M289 in 2013 ([Table 5](#tbl0025){ref-type="table"}). All the G2P\[4\] strains analyzed had 4--7 amino acids in the neutralization domain which are different from those of G2 component of pentavalent vaccine (RotaTeq) and G2 prototype strain DS-1, as described previously for recent G2P\[4\] rotaviruses ([@bib0010]; [@bib0085]; [@bib0235]). Although VP4 neutralization domains of G2P\[4\] HRVs in 2010 and 2013 were also similar to those of MMC88 strain, all the eight strains in 2013 had different amino acids at position 88 (A) and 114 (P) from those in the G2P\[4\] strains in 2005 and 2010 as well as DS-1 strain (Q and T, respectively) ([Table 6a](#tbl0030){ref-type="table"}, [Table 6b](#tbl0035){ref-type="table"}).

4. Discussion {#sec0035}
=============

Recent molecular epidemiological studies of whole genome of G2P\[4\] HRVs for a long period conducted in Italy ([@bib0085]), and Japan ([@bib0045]) indicated that G2P\[4\] strains distributed globally appeared to have undergone intragenotype reassortment, observed by change of lineages of all the viral protein genes from the 1970s until 2011. As a result, it was suggested that major changes of genomic composition of the G2P\[4\] HRVs might occur in the early 2000s, when the "new" global G2P\[4\] HRV strains have been widespread replacing the "old" G2P\[4\] strains. In the present study, all the 16 RVA strains in 2010 and 2013 in Bangladesh belonged to the group of "new" G2P\[4\] HRVs clustering with recent global G2P\[4\] strains. This view was supported by the fact that amino acid residues in the VP7 antigenic regions were the same as those found in recent global G2P\[4\] HRVs, distinguishing them from old strains as well as the G2 component of pentavalent vaccine ([@bib0010]; [@bib0030]; [@bib0040]; [@bib0050]; [@bib0090]; [@bib0235]).

It was noted in the present study that change and replacement of sublineages and lineage constellations were observed for a short period of 3 years, although all the gene segments exhibited high sequence identities to each other. Individual viral genome segments were differentiated into 1--3 sublineages in a single lineage of individual genotypes (2 lineages in M2-VP3 and 3 lineages in E2-NSP4 genes). Thereby the 16 Bangladeshi strains were classified into four clades containing 8 lineage constellations, revealing the presence of three clades with four lineage constellations in 2010, and one clade with four constellations in 2013. Therefore, co-existence of multiple G2P\[4\] HRV strains with different lineage constellations was demonstrated in Bangladesh in the present study. Using classification of lineage (not sublineage as in the present study) of rotavirus genes, different allele constellations have been identified for G2P\[4\] HRV in a single winter season in a US community ([@bib0030]), and also for G1, G3, and G4 RVAs in different study settings worldwide ([@bib0155]; [@bib0160]; [@bib0165]; [@bib0230]).

Through analysis of VP7 from a number of G2 strains in the last 39 years in the US, lineage turnover was presumed to occur every 7 years on an average, generating new dominant strains ([@bib0030]). Afrad and coworkers revealed that multiple lineages of G1 and G2HRVs co-circulated for one or a few seasons, followed by frequent replacement with different lineages, by the analysis of the VP7 gene of HRVs detected for more than 20 years in Bangladesh ([@bib0010]). Therefore, lineage of the G2-VP7 gene is considered to change frequently in global level, as suggested by another study in Australia ([@bib0050]). Our present study, despite a short period, change of sublineages was documented for a whole genome, providing more detailed evidences than lineage.

In our study in Bangladesh, lineage groups (clade A-C) in 2010 were considered to be replaced by clade D in 2013. However, clade A had VP1, VP3, and NSP4 genes belonging to sublineage Va which was commonly found in clade D. Therefore, it is suggested that clade A HRVs in 2010 were one of the ancestral viruses to generate clade D HRVs in 2013. Viral genome segments of clade D HRV were mostly assigned to sublineage Va, which was unique to present Bangladeshi strains in 2013 without clustering with other global strains. This finding suggested that strains of clade D may be newly emerging G2P\[4\] HRVs in Bangladesh. Furthermore, VP4 of clade D HRVs characteristically possess alanine and proline at position 88 and 114 in the antigenic region, respectively. Both amino acids are not found in Bangladeshi strain MMC88 as well as global G2P\[4\] strains ([@bib0085]). Proline at position 114 is conserved in P\[8\] VP4, and also identified in only a few G2P\[4\] Brazilian strains in 2010 ([@bib0090]). It is therefore important to survey global spread and distribution of the G2P\[4\] RVA genes belonging to the clade D, and their antigenic characteristics of VP4. In contrast, clade C strains that were detected in only 2010 had asparagine at position 130 of VP7, like strains DS-1 and TB-Chen, suggesting that these strains have a trait of old G2HRVs.

VP3 gene of a Bangladeshi strain MMC88 in 2005 clustered with most G2P\[4\] HRV strains in the sublineage Va. The MMC88-VP3 gene is genetically related to caprine rotavirus strain GO34 from Bangladesh and suggests an animal origin ([@bib0065]; [@bib0080]), while another G2P\[4\] strain, MMC6, detected in 2005 has a VP3 gene frequently detected in HRVs. It was interesting in the present study that such caprine-like VP3 gene was identified in most of G2P\[4\] strains in 2010 and 2013 (lineage Va), suggesting successful adaptation of this gene to Bangladeshi HRVs of DS-1 genogroup. This may be evidenced by the fact that the VP3 genes clustering with the caprine strain and MMC88 have been detected in USA, Brazil, Thailand, Australia, and Italy ([@bib0030]; [@bib0085]; [@bib0090]).

In conclusion, our present study elucidated that multiple, genetically distinct G2P\[4\] HRVs are circulating in north-central Bangladesh, by whole genome-based phylogenetic analysis. Replacement of genomic constellations, and amino acid change in the antigenic region in VP4 were observed even for a short period from 2010 to 2013. Further continuous surveillance of G2P\[4\] HRVs is necessary at a global level to understand their evolutionary state.
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###### 

Date, age, and sex of the patients infected with RVA strains.

Table 1

  RVA strain                                Date of collection (year/month)   Age   Sex
  ----------------------------------------- --------------------------------- ----- -----
  RVA/Human-wt/BGN/J331/2010/G2P\[4\]^\*^   2010.2                            1Y    M
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]       2010.2                            24Y   M
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]       2010.2                            12Y   M
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]       2010.2                            6Y    M
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]       2010.1                            20Y   M
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]       2010.1                            6M    M
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]       2010.1                            20Y   M
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]       2010.1                            5Y    M
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]       2010.1                            22Y   M
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]       2013.9                            8M    F
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]       2013.8                            4M    M
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]       2013.8                            10M   M
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]       2013.8                            2Y    M
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]       2013.8                            3Y    M
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]       2013.12                           3M    M
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]       2013.11                           5M    M
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]       2013.11                           6M    F

\*This strain had Wa-like genotypes in VP3 gene (M1) and NSP5/6 gene (H1) in the DS-1-like genotype constellation. Because the possibility of mixed infection could not be excluded, this strain was not included in the phylogenetic analysis.

###### 

Primers designed in the present study.

Table 2

  ---------------------------------------------------------------------------------
  Gene segment   Primer   Sequence(5\'--3\')                Nucleotide\    Size
                                                            Position^\*^   
  -------------- -------- --------------------------------- -------------- --------
  VP1            390R     CAT CAA TGA GTC AGT GTA TTC       408--388       21 mer

  VP1            2640R    GGT TTT ATG TCT TTA AGT ATG TCG   2666--2643     24 mer

  VP2            480F     GGG GAC TAT GAT GTG AGA GAG       485--505       21 mer

  VP2            306F     CCA ACA TTC GAA CCT AAA GAG ACG   299--322       24 mer

  VP2            1014F    GGC GAG ATC GGT AGT ACC AG        997--1016      20 mer

  VP3            2195R    GTA CCA CAT CTC ACA TTT GGC G     2195--2216     22 mer

  VP3            1860R    CAC ATG TCC AGA CAC TGA ATT CTC   1888--1865     24 mer

  VP3            2427R    TCG TGA TTG TCC AAA CGT GAT G     2425--2404     22 mer

  VP3            1725R    CCC ATA TGA TTT GCA TAT TGA TC    1752--1730     23 mer

  VP3            2124F    ATA TAG TAT AAC TTA TGC TGA CG    2113--2135     23 mer

  VP4            2091F    GGA TAC ACT TAA TGA GAT CCC       2091--2111     21 mer

  VP4            1215F    CTA TTA TGA ATG GCG GTGCTG        1190--1210     21 mer

  NSP1           200R     ATG TTG ACA ACA ATC TAA GC        175--156       20 mer

  NSP1           600F     ATG TAT TAC TGC TAG ATA GC        576--595       20 mer

  NSP4           550F     AGA GGT TGA GCT GCC GTC GTC       569--589       21 mer

  NSP4           500R     TAG CGT TTT CAC GTT CTT TTG       509--489       21 mer
  ---------------------------------------------------------------------------------

\*These positions correspond to individual gene segments of G2P\[4\] HRV.

###### 

GeneBank accesseion numbers for the 11gene segments of 16 G2P\[4\] RVA strains in Mymensingh, Bangladesh.

Table 3

  Strain                                Viral gene segment                                                                                                      
  ------------------------------------- -------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]   KU199270             KU199271   KU199272   KU199273   KU199274   KU199275   KU199276   KU199277   KU199278   KU199279   KU199280
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]   KU248372             KU248373   KU248374   KU248375   KU248376   KU248377   KU248378   KU248379   KU248380   KU248381   KU248382
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]   KU248383             KU248384   KU248385   KU248386   KU248387   KU248388   KU248389   KU248390   KU248391   KU248392   KU248393
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]   KU248394             KU248395   KU248396   KU248397   KU248398   KU248399   KU248400   KU248401   KU248402   KU248403   KU248404
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]   KU248405             KU248406   KU248407   KU248408   KU248409   KU248410   KU248411   KU248412   KU248413   KU248414   KU248415
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]   KU248416             KU248417   KU248418   KU248419   KU248420   KU248421   KU248422   KU248423   KU248424   KU248425   KU248426
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]   KU356574             KU356575   KU356576   KU356577   KU356578   KU356579   KU356580   KU356581   KU356582   KU356583   KU356584
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]   KU356585             KU356586   KU356587   KU356588   KU356589   KU356590   KU356591   KU356592   KU356593   KU356594   KU356595
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]   KU199281             KU199282   KU199283   KU199284   KU199285   KU199286   KU199287   KU199288   KU199289   KU199290   KU199291
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]   KU356596             KU356597   KU356598   KU356599   KU356600   KU356601   KU356602   KU356603   KU356604   KU356605   KU356606
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]   KU356607             KU356608   KU356609   KU356610   KU356611   KU356612   KU356613   KU356614   KU356615   KU356616   KU356617
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]   KU356618             KU356619   KU356620   KU356621   KU356622   KU356623   KU356624   KU356625   KU356626   KU356627   KU356628
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]   KU356629             KU356630   KU356631   KU356632   KU356633   KU356634   KU356635   KU356636   KU356637   KU356638   KU356639
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]   KU356640             KU356641   KU356642   KU356643   KU356644   KU356645   KU356646   KU356647   KU356648   KU356649   KU356650
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]   KU356651             KU356652   KU356653   KU356654   KU356655   KU356656   KU356657   KU356658   KU356659   KU356660   KU356661
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]   KU356662             KU356663   KU356664   KU356665   KU356666   KU356667   KU356668   KU356669   KU356670   KU356671   KU356672

###### 

Lineages (sublineages) of 11 genome segments detected in Mymensingh, Bangladesh.

Table 4

  RVA strain                             Lineage (sublineages)[\*](#tblfn0005){ref-type="table-fn"} of viral protein genes (genotype : G2-P\[4\]-I2-R2-C2-M2-A2-N2-T2-E2-H2)   Lineage constellation[\#](#tblfn0010){ref-type="table-fn"}   Clade[\#](#tblfn0010){ref-type="table-fn"}                                                       
  -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------- ---- ---- ----- ---- ---- ---- ----- ---- --------- ---
  RVA/Human-wt/BGN/MMC6/2005/G2P\[4\]    V                                                                                                                                     Vc                                                           Vb                                           Vb   Vc   VII   Vb   Vb   Vc   VI    Vb             
  RVA/Human-wt/BGN/MMC88/2005/G2P\[4\]   V                                                                                                                                     Vb                                                           V                                            Vb   Vb   Va    V    V    V    VII   V              
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Va   Vb   Va    V    V    Vb   V     V    2010--4   A
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Vb   Vb   Va    V    V    V    VII   V    2010--2   B
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Vb   Vb   Va    V    V    V    VII   V    2010--2   B
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Va   Vb   Va    V    V    Vb   Va    V    2010--1   A
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Va   Vb   Va    V    V    Vb   Va    V    2010--1   A
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]    V                                                                                                                                     Vb                                                           V                                            Va   Vb   Va    V    V    Vb   Va    V    2010--1   A
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]    V                                                                                                                                     Vc                                                           Vb                                           Vb   Vc   VI    Vb   Vb   Vc   VI    Vb   2010--3   C
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]    V                                                                                                                                     Vc                                                           Vb                                           Vb   Vc   VI    Vb   Vb   Vc   VI    Vb   2010--3   C
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           Va   Va   Va    Va   Va   Va   Va    Va   2013--1   D
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           Va   Va   Va    Va   Va   Va   Va    Va   2013--1   D
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           Va   Va   Va    Va   Va   Va   Va    Va   2013--1   D
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           Va   Va   Va    Va   Va   Va   Va    Va   2013--1   D
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           Va   Va   Va    Va   Va   Va   Va    Va   2013--1   D
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]    Va                                                                                                                                    V                                                            Va                                           V    Vb   Va    Va   Va   V    Va    Va   2013--2   D
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]    Va                                                                                                                                    Va                                                           Va                                           V    Va   Va    Va   Va   Va   Vb    Va   2013--3   D
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]    V                                                                                                                                     Va                                                           Va                                           V    Va   Va    Va   Va   V    Vb    Va   2013--4   D

Lineage (sublineage) is the same as that described in [Fig. 1](#fig0005){ref-type="fig"}.

Lineage constellation was designated based on combination of lineages/sublineages of 11 genome segments, and clades A-D were defined as group of lineage constellations having five or more identical sublineages of lineage V (and lineage VI and VII in some strains).

###### 

Alignment of the amino acid residues defining the neutralization domains of VP7 (7-1a, 7-1b, and 7--2) between RotaTeq™ G2 component and G2 strains DS-1, TB-Chen, MMC88, and 16 G2P\[4\] RVA strains in Bangladesh.

Table 5

  RVA strain                                    7-1a                                                                              7-1b                                            7-2                                                                                                                                                                                                                                                                                                                                 
  --------------------------------------------- ---------------------------------------- ---------------------------------------- ------ ---------------------------------------- ---------------------------------------- --- --- --- --- --- --- --- ---------------------------------------- --- -- --- --- --- ---------------------------------------- --- ---------------------------------------- -- --- --- --- --- --- --- ---------------------------------------- ---------------------------------------- ---
  RVA/Vaccine/USA/RotaTeq SC2-9/1992/G2P\[5\]   A                                        N                                        S      D                                        E                                        W   E   N   Q   D   T   M   N                                        K      Q   D   V   S                                        N   S                                           R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-tc/USA/DS-1/1976/G2P\[4\]           A                                        N                                        S      D                                        E                                        W   E   N   Q   D   T   M   N                                        K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   S                                           R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-tc/CHN/TB-Chen/1996/G2P\[4\]        A                                        N                                        S      D                                        E                                        W   E   N   Q   D   N   V   N                                        K      Q   D   V   N[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/MMC88/2005/G2P\[4\]          T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]           T^\*^                                    N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   N                                        K      Q   D   V   D^\*^                                    N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        T[\*](#tblfn0015){ref-type="table-fn"}   G
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   N                                        K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   I[\*](#tblfn0015){ref-type="table-fn"}   S      N[\*](#tblfn0015){ref-type="table-fn"}   V[\*](#tblfn0015){ref-type="table-fn"}   W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   V[\*](#tblfn0015){ref-type="table-fn"}   A[\*](#tblfn0015){ref-type="table-fn"}   G
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]           T[\*](#tblfn0015){ref-type="table-fn"}   N                                        S      N[\*](#tblfn0015){ref-type="table-fn"}   E                                        W   E   N   Q   D   T   M   D[\*](#tblfn0015){ref-type="table-fn"}   K      Q   D   V   D[\*](#tblfn0015){ref-type="table-fn"}   N   N[\*](#tblfn0015){ref-type="table-fn"}      R   D   N   T   S   D   I                                        S                                        G

Residues that differ from those of RotaTeq™ (G2 component).

###### 

Alignment of the amino acid residues defining the neutralization domains of VP4, VP8 subunit (8--1, 8--2, 8--3 and 8--4) between the P\[4\] strains (DS-1, TB-Chen, MMC88) and 16 G2P\[4\] RVA strains in Bangladesh.

Table 6a

  RVA strain                               8-1       8-2       8-3       8-4                                                                                                                                                                                               
  ---------------------------------------- ----- --- ----- --- ----- --- ----- --- --- --- --- -- --- --- -- --- ---------------------------------------- --- --- --- --- --- ---------------------------------------- --- -- --- ---------------------------------------- ---
  RVA/Human-tc/USA/DS-1/1976/G2P\[4\]      D     S   H     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   N                                        D      N   T                                        D
  RVA/Human-tc/CHN/TB-Chen/1996/G2P\[4\]   D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   N                                        D      N   T                                        N
  RVA/Human-wt/BGN/MMC88/2005/G2P\[4\]     D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   Q                                        T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   T                                        D
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]      D     S   Q     D   S     T   D     L   N   N   I      T   A      S   P[\*](#tblfn0020){ref-type="table-fn"}   T   N   N   E   N   S[\*](#tblfn0020){ref-type="table-fn"}   D      N   A[\*](#tblfn0020){ref-type="table-fn"}   D

Residues that differ from those of strains DS-1 and TB-Chen.

###### 

Alignment of the amino acid residues defining the neutralization domains of VP4, VP5 subunit (5--1, 5--2, 5--3, 5--4 and 5--5) between the P\[4\] strains (DS-1, TB-Chen, MMC88) and 16 G2P\[4\] RVA strains in Bangladesh.

Table 6b

  RVA strain                               5-1       5-2       5-3       5-4       5-5                        
  ---------------------------------------- ----- --- ----- --- ----- --- ----- --- ----- --- -- --- -- --- -- ---
  RVA/Human-tc/USA/DS-1/1976/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-tc/CHN/TB-Chen/1996/G2P\[4\]   Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/MMC88/2005/G2P\[4\]     Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J306/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J303/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J300/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J266/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J265/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J263/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J253/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/J251/2010/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M334/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M315/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M313/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M312/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M310/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M292/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M289/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
  RVA/Human-wt/BGN/M282/2013/G2P\[4\]      Y     F   L     W   P     G   R     T         P      T      L      R
